This market snapshot provides an analysis of the global market for atrial septal occlusion devices.
These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth.
This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- Abbott
- atHeart Medical
- Cardia
- Hanyu Medical
- Lifetech Scientific
- Occlutech
- W.L. Gore